|
Volumn 137, Issue 17, 2002, Pages 609-612
|
Better medication surveillance spares disease burden and money. 90,000 Unnecessary hospital admissions caused by side effects;90,000 Onnodige ziekenhuisopnames door bijwerkingen: Betere medicatiebegeleiding bespaart ziektelast én geld
|
Author keywords
Adverse effects; Economics; Hospitalization; Medication surveillance; Pharmaceutical
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTICOAGULANT AGENT;
ANTIDIABETIC AGENT;
ANTINEOPLASTIC AGENT;
CARDIOVASCULAR AGENT;
CORTICOSTEROID;
DIURETIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
PSYCHOTROPIC AGENT;
AGE;
ARTICLE;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
COST CONTROL;
DRUG INDUCED DISEASE;
DRUG OVERDOSE;
DRUG SURVEILLANCE PROGRAM;
ELDERLY CARE;
GASTROINTESTINAL DISEASE;
HEALTH CARE COST;
HOSPITAL ADMISSION;
HOSPITALIZATION;
HUMAN;
MEDLINE;
META ANALYSIS;
NETHERLANDS;
POLYPHARMACY;
STATISTICAL ANALYSIS;
|
EID: 0037177584
PISSN: 00316911
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|